High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
811.44M
+1.34%
0.449
-13.62%
888.43M
+2.78%
0.642
+7.07%
1.01B
+3.6%
0.920
+21.02%
Estimates Revision
The market is revising Upward the revenue expectations for Bruker Corporation (BRKR) for FY2025, with the revenue forecasts being adjusted by 0.47% over the past three months. During the same period, the stock price has changed by -11.34%.
Revenue Estimates for FY2025
Revise Upward
+0.47%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-8.32%
In Past 3 Month
Stock Price
Go Down
-11.34%
In Past 3 Month
10 Analyst Rating
0Wall Street analysts forecast BRKR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRKR is 50.63 USD with a low forecast of 40.00 USD and a high forecast of 61.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
4 Hold
0 Sell
Moderate Buy
0Current: 39.870
Low
40.00
Averages
50.63
High
61.00
0Current: 39.870
Low
40.00
Averages
50.63
High
61.00
Citigroup
Patrick Donnelly
Strong Buy
to
Hold
Downgrades
$50 → $40
2025-05-22
Reason
Citigroup
Patrick Donnelly
Price Target
$50 → $40
2025-05-22
Downgrades
Strong Buy
to
Hold
Reason
Stifel
Daniel Arias
Hold
Maintains
$57 → $48
2025-05-08
Reason
Stifel
Daniel Arias
Price Target
$57 → $48
2025-05-08
Maintains
Hold
Reason
Goldman Sachs
Matthew Sykes
Hold
Maintains
$50 → $45
2025-05-08
Reason
Goldman Sachs
Matthew Sykes
Price Target
$50 → $45
2025-05-08
Maintains
Hold
Reason
Barclays
Luke Sergott
Buy
Maintains
$50 → $46
2025-05-08
Reason
Barclays
Luke Sergott
Price Target
$50 → $46
2025-05-08
Maintains
Buy
Reason
UBS
Dan Leonard
Hold
Maintains
$57 → $45
2025-05-08
Reason
UBS
Dan Leonard
Price Target
$57 → $45
2025-05-08
Maintains
Hold
Reason
Wells Fargo
Brandon Couillard
Buy
Maintains
$75 → $60
2025-04-17
Reason
Wells Fargo
Brandon Couillard
Price Target
$75 → $60
2025-04-17
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Bruker Corp (BRKR.O) is 15.76, compared to its 5-year average forward P/E of 27.72. For a more detailed relative valuation and DCF analysis to assess Bruker Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
27.72
Current PE
15.76
Overvalued PE
33.65
Undervalued PE
21.78
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Undervalued
5Y Average EV/EBITDA
18.12
Current EV/EBITDA
11.94
Overvalued EV/EBITDA
21.13
Undervalued EV/EBITDA
15.12
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Undervalued
5Y Average PS
3.47
Current PS
1.68
Overvalued PS
4.30
Undervalued PS
2.63
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
BRKR News & Events
Events Timeline
(ET)
2025-06-03
07:10:11
Bruker acquires biocrates life sciences, terms undisclosed
2025-06-02 (ET)
2025-06-02
07:24:03
Bruker launches new timsUltra AIP system
2025-06-02
07:13:57
Bruker unveils new proteoElute nanoLC system, PepSep Advanced nLC columns
Sign Up For More Events
Sign Up For More Events
News
Preview
3.5
06-03NewsfilterBruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
Preview
8.5
06-03NewsfilterBruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
Preview
5.0
06-02NewsfilterBruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
Sign Up For More News
People Also Watch
FAQ
What is Bruker Corp (BRKR) stock price today?
What is Bruker Corp (BRKR)'s business?
What is the price predicton of BRKR Stock?
What is Bruker Corp (BRKR)'s revenue for the last quarter?
What is Bruker Corp (BRKR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Bruker Corp (BRKR)'s fundamentals?
How many employees does Bruker Corp (BRKR). have?